Table GPS-4. Lifetime prevalence of drug use by age, gender and country, most recent national general population survey available since 2000 [see all tables in this series...]

Part (i) All adults male (aged 15–64)

Country		Geographical area	Year	Reference	Age range all adults	Sample size all adults	Cannabis (%)	Cocaine (%) (1)	Amphetamines (%) (2)	Ecstasy (%) (3)	LSD (%)
Belgium		National	2008	(7)	15–64	6792	18.0	:	:	:	:
Bulgaria		National	2008	(3)	15–64	5139	9.2	2.2	2.6	2.2	0.3
Czech Republic	(4)	National	2009	(5)	15–64	1486	33.2	1.9	2.8	6.1	:
Denmark		National	2010	(6)	16–64	11611	39.7	6.8	9.2	3.2	2.3
Germany		National	2009	(8)	18–64	8030	30.3	4.5	5.1	3.0	3.3
Estonia		National	2008	(3)	15–64	1401	:	:	:	:	:
Ireland		National	2006–07	(5)	15–64	4967	27.0	7.0	4.6	7.2	4.0
Greece		National (except Aegean and Ionian Islands)	2004	(3)	15–64	4351	13.7	1.2	0.1	0.5	0.4
Spain		National	2009	(8)	15–64	20109	40.5	15.1	5.6	7.1	:
France		National	2005	(6)	15–64	25879	37.9	3.9	1.9	2.9	2.4
Italy		National	2008	(4)	15–64	10940	36.6	8.7	3.7	4.2	:
Cyprus		National	2009	(2)	15–64	3385	18.0	4.8	1.2	3.4	2.1
Latvia		National	2007	(2)	15–64	4500	17.2	3.1	5.4	7.2	2.1
Lithuania		National	2008	(2)	15–64	4777	15.8	0.7	2.2	2.6	0.6
Luxembourg		:	:	:	:	:	:	:	:	:	:
Hungary		National	2007	(3)	18–64	2710	11.0	1.0	2.5	3.2	1.4
Malta		National	2001	(1)	18–64	1755	5.3	:	:	:	:
Netherlands		National	2005	(3)	15–64	4516	29.1	5.2	3.2	6.6	2.3
Austria		National	2008	(2)	15–64	3761	17.5	3.6	3.4	3.5	3.0
Poland		National	2006	(2)	15–64	2859	13.4	1.3	3.5	1.8	1.5
Portugal		National	2007	(2)	15–64	12202	18.4	3.2	1.5	2.1	1.1
Romania		National	2007	(2)	15–64	6797	2.3	0.1	0.1	0.5	0.0
Slovenia		National	2007	(1)	15–64	1724	:	:	:	:	:
Slovakia		National	2006	(6)	15–64	1305	23.6	1.9	1.9	6.1	:
Finland		National	2006	(7)	15–64	2802	16.5	1.7	3.1	1.8	1.7
Sweden		National	2008	(5)	15–64	22095	23.1	3.8	6.8	2.3	:
Sweden		National	2010	(12)	16-64	7315	18.0	:	:	:	:
United Kingdom		England and Wales	2009-10	(13)	16-59	26199	36.7	11.5	14.6	11.4	7.5
United Kingdom		Northern Ireland	2008-09	(18)	16–64	2438	23.7	5.9	8.8	9.1	5.5
United Kingdom		Scotland	2008-09	(22)	16–59	8488	34.3	11.8	12.2	12.1	9.2
United Kingdom		United Kingdom	2006	(24)	16–59	:	36.3	10.2	14.8	10.1	8.1
Croatia		:	:	:	:	:	:	:	:	:	:
Turkey		:	:	:	:	:	:	:	:	:	:
Norway		National	2009	(3)	15–64	1624	16.2	3.3	4.4	1.1	1.1

Notes:

 This table presents the methods and results for the last surveys available in each country. The number indicated in the ‘Ref.’ column is the reference to the corresponding survey in the table presenting all surveys available for each country in Table GPS-7. For sources of each survey see Table GPS-0. 

 (1) Cocaine, any form. 

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy. 

 (3) For Spain: ecstasy and other designer drugs. 

 (4) The most recent General population surveys reported by the Czech Republic display a wide variation in results, the reason for which is being explored, but may be due to differing sampling methods. The data is provided for information, but given the lack of comparability between surveys should be treated with caution. 

 Sample sizes refer to the whole age group. Specific sample sizes by gender are not available at the moment but will be collected in the future. 

 This table aims to present an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as reference point for the 1993 survey.  

 In surveys with small sample sizes results should be interpreted with caution. 

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups. 

 For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 See Table GPS-0. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)